Enanta Pharmaceuticals Inc. buy Rodman & Renshaw
Start price
26.03.26
/
50%
€10.60
Target price
26.03.27
€17.30
Performance (%)
15.09%
Price
26.06.26
€12.20
Summary
This prediction is currently active. The BUY prediction by Rodman___Renshaw currently has a performance of 15.09%. This prediction currently runs until 26.03.27. The prediction end date can be changed by Rodman___Renshaw at any time. Rodman___Renshaw has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Enanta Pharmaceuticals Inc. | 12.963% | 12.963% |
| iShares Core DAX® | -1,36 % | -2,16 % |
| iShares Nasdaq 100 | -3,70 % | -1,16 % |
| iShares Nikkei 225® | -2,51 % | 7,93 % |
| iShares S&P 500 | -1,66 % | -0,70 % |
Comments by Rodman___Renshaw for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Enanta Pharmaceuticals (ENTA) is now covered by Rodman & Renshaw. They set a "buy" rating and a $20.00 price target on the stock.
Ratings data for ENTA provided by MarketBeat